Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
Add more filters










Publication year range
1.
Cell Death Differ ; 15(9): 1396-407, 2008 Sep.
Article in English | MEDLINE | ID: mdl-18437160

ABSTRACT

The RNA alphavirus Semliki Forest (SFV) triggers apoptosis in various mammalian cells, but it has remained controversial at what infection stage and by which signalling pathways host cells are killed. Both RNA synthesis-dependent and -independent initiation processes and mitochondrial as well as death receptor signalling pathways have been implicated. Here, we show that SFV-induced apoptosis is initiated at the level of RNA replication or thereafter. Moreover, by expressing antiapoptotic genes from recombinant SFV (replicons) and by using neutralizing reagents and gene-knockout cells, we provide clear evidence that SFV does not require CD95L-, TRAIL (tumor necrosis factor-related apoptosis-inducing ligand)- or tumor necrosis factor-mediated signalling but mitochondrial Bak to trigger cytochrome c release, the fall in the mitochondrial membrane potential, apoptotic protease-activating factor-1/caspase-9 apoptosome formation and caspase-3/-7 activation. Of seven BH3-only proteins tested, only Bid contributed to effective SFV-induced apoptosis. However, caspase-8 activation and Bid cleavage occurred downstream of Bax/Bak, indicating that truncated Bid formation serves to amplify rather than trigger SFV-induced apoptosis. Our data show that SFV sequentially activates a mitochondrial, Bak-mediated, caspase-8-dependent and Bid-mediated death signalling pathway that can be accurately dissected with gene-knockout cells and SFV replicons carrying antiapoptotic genes.


Subject(s)
Apoptosis , RNA, Viral/biosynthesis , Semliki forest virus/genetics , bcl-2 Homologous Antagonist-Killer Protein/metabolism , Aedes/cytology , Animals , Apoptosis Regulatory Proteins/genetics , BH3 Interacting Domain Death Agonist Protein/physiology , Caspase 8/metabolism , Caspases/metabolism , Cytochromes c/metabolism , Genome, Viral , Mitochondria/metabolism , Replicon , Signal Transduction , bcl-2-Associated X Protein/metabolism
2.
Cell Death Differ ; 14(6): 1172-80, 2007 Jun.
Article in English | MEDLINE | ID: mdl-17396132

ABSTRACT

Cells exposed to sustained endoplasmic reticulum (ER) stress undergo programmed cell death and display features typical of apoptosis, such as cysteine aspartyl protease (caspase) activation, cytochrome c release, and DNA fragmentation. Here, we show that the execution of cell death induced by ER stress is mediated via the proteasome. Inhibition of the proteasome by lactacystin prevented ER stress-induced degradation of Bcl-2, release of cytochrome c, processing of effector caspase-3, and exposure of phosphatidylserine. Owing to the ability of lactacystin to inhibit cytochrome c release, we propose that the pro-apoptotic activity of the proteasome lies upstream of mitochondrial activation. Thus, the proteasome serves as a principal mediator of ER stress-induced cell death in this system.


Subject(s)
Apoptosis/physiology , Endoplasmic Reticulum/metabolism , Fibroblasts/metabolism , Proteasome Endopeptidase Complex/metabolism , Acetylcysteine/analogs & derivatives , Acetylcysteine/pharmacology , Animals , Apoptosis/drug effects , Blotting, Western , Brefeldin A/pharmacology , Caspase 3/metabolism , Cells, Cultured , Chlorhexidine/pharmacology , Cytochromes c/metabolism , DNA Fragmentation/drug effects , Electrophoresis, Polyacrylamide Gel , Endoplasmic Reticulum/drug effects , Fibroblasts/cytology , Fibroblasts/drug effects , Mitochondrial Membranes/metabolism , Models, Biological , Phosphatidylserines/metabolism , Proteasome Inhibitors , Proto-Oncogene Proteins c-bcl-2/metabolism , Rats , Sulfones/pharmacology , Temperature , Ubiquitin-Activating Enzymes/genetics , Ubiquitin-Activating Enzymes/metabolism
3.
Cell Death Differ ; 10(10): 1188-203, 2003 Oct.
Article in English | MEDLINE | ID: mdl-14502242

ABSTRACT

Effective execution of apoptosis requires the activation of caspases. However, in many cases, broad-range caspase inhibitors such as Z-VAD.fmk do not inhibit cell death because death signaling continues via basal caspase activities or caspase-independent processes. Although death mediators acting under caspase-inhibiting conditions have been identified, it remains unknown whether they trigger a physiologically relevant cell death that shows typical signs of apoptosis, including phosphatidylserine (PS) exposure and the removal of apoptotic cells by phagocytosis. Here we show that cells treated with ER stress drugs or deprived of IL-3 still show hallmarks of apoptosis such as cell shrinkage, membrane blebbing, mitochondrial release of cytochrome c, PS exposure and phagocytosis in the presence of Z-VAD.fmk. Cotreatment of the stressed cells with Z-VAD.fmk and the serine protease inhibitor Pefabloc (AEBSF) inhibited all these events, indicating that serine proteases mediated the apoptosis-like cell death and phagocytosis under these conditions. The serine proteases were found to act upstream of an increase in mitochondrial membrane permeability as opposed to the serine protease Omi/HtrA2 which is released from mitochondria at a later stage. Thus, despite caspase inhibition or basal caspase activities, cells can still be phagocytosed and killed in an apoptosis-like fashion by a serine protease-mediated mechanism that damages the mitochondrial membrane.


Subject(s)
Apoptosis/physiology , Caspase Inhibitors , Phagocytosis/physiology , Serine Endopeptidases/metabolism , Amino Acid Chloromethyl Ketones/chemistry , Amino Acid Chloromethyl Ketones/metabolism , Amino Acid Chloromethyl Ketones/pharmacology , Animals , Antibodies, Monoclonal/pharmacology , Apoptosis/drug effects , Blotting, Western , Brefeldin A/pharmacology , Caspase 3 , Caspases/chemistry , Caspases/metabolism , Cell Adhesion/drug effects , Cell Adhesion/physiology , Cell Line, Tumor , Cycloheximide/pharmacology , Fibroblasts/cytology , Fibroblasts/drug effects , Fibroblasts/metabolism , Flow Cytometry , Gene Expression Regulation , HeLa Cells , Humans , Interleukin-3/deficiency , Interleukin-3/pharmacology , Mice , Microscopy, Fluorescence , Microscopy, Phase-Contrast , Models, Biological , Phagocytosis/drug effects , Proto-Oncogene Proteins c-bcl-2/genetics , Proto-Oncogene Proteins c-bcl-2/metabolism , Proto-Oncogene Proteins c-bcl-2/pharmacology , Rats , Sulfones/pharmacology , Thapsigargin/pharmacology , Tunicamycin/pharmacology , U937 Cells , fas Receptor/immunology
8.
Phys Rev A ; 50(1): 123-131, 1994 Jul.
Article in English | MEDLINE | ID: mdl-9910876
SELECTION OF CITATIONS
SEARCH DETAIL
...